What have we learned from the nitrosamine crisis? Kumar Jeetendra | May 8, 2021 The pharmaceutical industry is facing an ongoing issue with genotoxic impurities (GTIs). Over the past year, we have witnessed genotoxic impurities affect several drugs, including those used to treat elevated blood pressure, heartburn and acid reflux. Angiotensin II receptor blockers (including valsartan, losartan and irbesartan), along with ranitidine and nizatidine, were recalled to investigate several …
Detecting Nitrosamine Impurities: Advances in Analytical Techniques Kumar Jeetendra | October 30, 2023 Potentially dangerous substances known as nitrosamines can appear as contaminants in a range of consumer goods. To guarantee the safety of the product, nitrosamine impurities must be found and measured. This article examines the most current developments in nitrosamine detection analytical techniques, which improve our capacity to track and control their occurrence in consumer products. …
